Moralo oa Peptide o Etsang Pore: Tatellano ho Ts'ebetso ea Membrane

Moralo oa Peptide o Etsang Pore: Tatellano ho Ts'ebetso ea Membrane

Hobaneng ha Pono e Tloaelehileng ea Bohloeki-pele Pono ea Pore-Forming Peptide Design e sa Felletse

setšoantšo se arohaneng sa likholomo tse peli se bapisang chromatogram e hloekileng ea tlhoro e le 'ngoe ea RP-HPLC e nang le lera la schematic moo peptide e tšoanang e hlolehang ho theha st.

Maemo a tloaelehileng a ho lokolla peptide e sebetsang ka membrane ke nomoro e le 'ngoe: bohloeki ba sebaka sa reverse-phase HPLC, hangata ho kapa hodimo 95%, mmoho le bongata bo bongata bo netefatsang boima bo lebeletsweng bo sa fetoheng. Tekanyetso eo e molemo e le kannete, 'me ho bohlokoa ho bua ka nepo ka seo e se thehang. RP-HPLC e tlaleha bohloeki ba chromatographic, e bolelang karolo ea thepa e monyang UV e lutseng tlhorong e kholo, ha mass spectrometry e tlaleha boima bo sa fetoheng le, ka MS/MS, tshehetso ya karohano ya boemo ba tatelano (Karolo ea mekhoa ea PMC). Hammoho ba araba potso ea sebele: se entsoeng, mme e hlwekile hakakang.

Li-tiers ka botsona ke litumellano ho fapana le litlhoko. Hangata barekisi ba qotsa ≥95% sebaka sa RP-HPLC e le sebaka sa boemo ba lipatlisiso, ≥98% joalo ka lipatlisiso tsa sejoale-joale le mokato oa GMP, le ≥99% bakeng sa lisebelisoa tsa pele kapa tsa bongaka (peptide purity reference set, 2025). These are reported supplier conventions, not a compendial mandate.

Moralo oa Peptide o Etsang Pore: Tatellano ho Ts'ebetso ea Membrane

The view became dominant because it is cheap, fast, orthogonal, and sufficient for most non-membrane targets. Its origin is analytical-chemistry practice, not biophysics, which is where the first peptide purity testing limitations appear: percent-area purity does not name the impurities it excludes.

⚠️ Tlhokomeliso: percent-area purity does not quantify deletion sequences, truncations, co-eluting diastereomers, counterions (TFA, acetate, chloride) or water content, so net peptide content can differ from label weight (peptide purity-testing guide, 2026).

Moralo oa Peptide o Etsang Pore: Tatellano ho Ts'ebetso ea Membrane

Peptide Synthesis Two samples of equal nominal mass can therefore carry different effective concentrations, and neither certificate tells you whether the peptide inserts, oligomerizes, or forms a stable pore in a membrane.

Ke eng 2026 Pore-Formation Research Ha e le hantle e bontša

That reframing starts with the 2026 Nature Chemical Biology study from Deb and colleagues, e nkang pore-forming peptide design e le thepa e kentsoeng ka tatellano ho fapana le sephetho sa tlhoekiso.. Sehlopha se ile sa matha 51 µs ea matla a limolek'hule a mahoashe a se nang leeme (Martini 2.2 / LIKELETSO) ka nqane 150 li-pores tse entsoeng pele ho octameric transmembrane barrel ho POPC, tiisitsoe litselana ka 2 µs lipapiso tsa liathomo tsohle, ebe oa kopanngoa 22 li-peptides le ho li leka ka ho lutla ha calcein, planar bilayer electrophysiology, nako ea sebele AFM, CD, le GUV dextran transport (Mokhatlo oa Amerika oa Peptide, 2026-08-06).

Liphetho tse peli li bohlokoa ho mang kapa mang ea hlophisang tatellano. Ea pele, boits'oaro bo fihlile ka mokhoa o ikhethileng: boleng ba pore e le 'ngoe ea 0.116, 0.251, 0.353, le 0.424 nS (Mokhatlo oa Amerika oa Peptide, 2026-08-06). Sekoti sa moqomo, moo li-peptide li tsamaisanang le kanale e tsitsitseng, le lesoba la toroidal, moo lipid bilayer ka boeona e kobehang ka har'a lesela, hlahisa li-signature tse fapaneng tsa conductance, kahoo mohlala oa stepwise ke setšoantšo sa meralo ea meralo, eseng feela hore na peptide e tlanngoe hakae. Ea bobeli, AFM ea nako ea sebele e ile ea tšoara li-pores hoo e ka bang 6 nm bophara ka hare 20 metsotso ea ho eketsa peptide (Mokhatlo oa Amerika oa Peptide, 2026-08-06).

Pipeline e boetse e hloekisitsoe 52 dithempleite tatelano dumellehang ka lihlopha tse 'nè, e behiloe ka har'a sets'oants'o sa tšebelisano ho tsoa ho 150-peptide MD scan (Mokhatlo oa Amerika oa Peptide, 2026-08-06). Bala linomoro tseo e le maemo a teko, eseng li-constants: boleng bo bong le bo bong ba conductance ke ba mofuta o itseng oa bilayer, matla a ionic, le voltage, 'me ha ho le e' ngoe ea tsona e fetisetsang ka ho toba tsamaisong e fapaneng ea lera.

Kamoo Tatellano E Fetisang Peptide Pakeng Tsa Pore Phenotypes

'mapa oa helical-wheel le linear tatellano ea peptide ea amphipathic e setseng e 30 e nang le maemo a monko le lipara tsa letsoai la Arg-Asp tse tšoailoeng., e bonts'itsoeng hammoho

Yuniti e fetolang tatellano ea peptide le tšebetso ea membrane ke eona e nkang sebaka, eseng peptide. Liphetoho tse le 'ngoe kapa tse kopaneng li ka tsamaisa mokokotlo o le mong lipakeng tsa linaha tse tharo: ha ho ts'ebetso ea membrane, ho dutla ha nakoana, le lesoba le tsitsitseng.

Ho beoa ka monko ke leqhubu le hlakileng ka ho fetisisa. Ka meralo ea Deb et al, maemo a matle a monko a tlositsoeng ho tloha masalla 13 le 19 ka 30-salla konokono ho 13, 15, 8 le 26 ha mantlha a ne a khutsufatsoa ho 22 masalla, 'me ho sekamela ha helix ho fetohile ho tloha ho 50 ° ho ea ho 30 ° ho amana le lera le tloaelehileng (Mokhatlo oa Amerika oa Peptide, 2026-08-06). Tefiso e ka nka sebaka sa ankora eo: marokho a mane a letsoai a Arg-Asp ka sebopeho se seng le se seng a ile a boloka botšepehi ba pore leha ho tlositsoe monko o monate (Mokhatlo oa Amerika oa Peptide, 2026-08-06). Electrostatics e beha matla a ho khanna, kaha li-peptide tsa cationic li bonts'itse haholo 20 kJ mol⁻¹ kamano e kholoanyane bakeng sa anionic POPE:POPG ho feta li-bilayers tsa zwitterionic POPC (Mokhatlo oa Amerika oa Peptide, 2026-08-06).

Stereochemistry ke axis ea bobeli e ikemetseng. Ho fetola masala a mang le a mang a DpPorA ho ea ho D-enantiomer ea eona ho fetotse boitšoaro bo kopaneng ho tloha ho 4 nS ho 1.5 ± 0.3 nS ho +100 mV ka 1 M KCl (n = 75), le ka nqane 100 ho kenya karohano ea sebopeho sa D 75%/25% lipakeng tsa ~1.5 nS le ~4 nS state le PK⁺/PCl⁻ ≈ 7:1 (Fumana et al., Nat Common, 2022-09-14).

Sebopeho sa tatellano

Phello e lebeletsoeng ea lera

Assay e e lemohang

Helicity

Hore na peptide e ka pharalla ka bilayer joalo ka helix e tsoelang pele

Dichroism e chitja ho POPC vs POPE:POPG vesicles

Nako ea Hydrophobic

Botebo le botsitso ba ho kenngoa ha membrane

Tryptophan fluorescence shift; vesicle leakage kinetics

Ho beha tefiso

Lipid-headgroup selectivity le botsitso ba borokho ba letsoai

Monyetla oa Zeta; conductance ho anionic vs zwitterionic bilayers

Ho beha monko o monate

Interfacial anchoring le helix sekama

Oriented circular dichroism; li-angles tse sekameng tsa NMR tse tiileng

Geometry le ho sekama

Mehaho ea mofuta ofe: moqomo-moqomo, toroidal kapa β-sheet

Boitšoaro ba mocha o le mong; CD e hlophisitsoeng; FTIR Amide I

Lysine, masala a arginine le a bulkier a sebetsa joalo ka balebeli ba liheke tsa membrane-desorption, ho thibela ho kenya botebo kapa phetiso e ngata (PMC, 2021-12-24).

Hobaneng ha Teko ea Bohloeki e sa khone ho bolela esale pele ka Membrane Behaviour

Mohlomong u se u bone sena: linkho tse peli, boima bo tšoanang ba lebitso, setifikeiti se tšoanang, 'me e mong oa bona ha a itšoare ka tsela eo teko e reng e lokela ho itšoara ka eona. Setifikeiti ha se phoso. E araba potso e nyane ho feta eo u e botsang.

Reverse-phase HPLC le mass spectrometry li theha boitsebiso le bohloeki ba chromatographic. Ha e thehe lemeno kapa sebopeho sa bobeli, boemo ba oligomeric, boemo ba ho kopanya tlasa maemo a tlhaho, kapa boitšoaro ba lera; tseo li hloka litlhahlobo tse fapaneng tsa biophysical kapa tse thehiloeng liseleng (Tlhahlobo ea tlhahlobo ea PMC). Ho hloeka ha sebaka ka liperesente ho boetse ho na le khanyetso le pherekano ea metsi a setseng, kahoo lisampole tse peli tsa boima bo lekanang ka mabitso li ka fana ka likhakanyo tse fapaneng tse sebetsang hang ha li qhibilihisoa. Ho tsepamisa mohopolo ho fapaneng ho bolela ts'ebetso e fapaneng e hlakileng ea membrane, le ha tatelano e tshoana.

Liphetho tsa tšebetso li lerata ka mabaka a tsona. Litekanyetso tse fokolang tse thibelang khatello hangata li tsamaea ka mohato o le mong ho isa ho tse peli tsa phallo lipakeng tsa lilaboratori, basebelisi le mekhoa, le ho tlohela ditaolo, ho sebedisa inoculum e fosahetseng (boletsoeng joalo ka 5 × 10⁵ CFU/mL) kapa ho kheloha maemo a kholo ho ka khopamisa litholoana (Tlhahlobo ea mekhoa ea MIC, 2024). Bothata ba ho ikatisa bo atoloha ho bolela esale pele: ho a 2026 benchmark ea 48 e hatisitsoeng ka mekhoa ea ho bolela esale pele ea antimicrobial-peptide, ka tlase ho 25% li ne li ka ikatisa (BATTLE-AMP palo, bioRxiv, 2026). Eo ke letšoao la pele la mekhoa, eseng ea li-peptide, empa e beha litebello tsa hore na qeto ea moralo e ka rarolloa hakae pampiring.

Mona ke moo sebopeho sa peptide se tloahelehileng se fellang mme mosebetsi oa hau o qala.

Key Takeaway: tlhahlobo ea tokollo ea analytical e lehlakoreng la barekisi; liteko tsa membrane-function ke lehlakoreng la bareki.

Moralo o Betere oa Moralo oa Peptide oa Pore-Forming

Rala li-peptide tse etsang li-pore khahlano le meralo ea pore e shebiloeng le tlhahlobo ea sepheo, eseng khahlano le semelo sa bohloeki. Phetoho eo e le 'ngoe morerong oa moralo e hlophisa bocha morero oohle.

Melao-motheo e mehlano e latela ho tsoa ho 2026 data:

  • Khetha moaho pele. Etsa qeto ea hore na u batla barrel-stave, toroidal, kapa pore e senyehileng e senyehileng pele o ama tatellano, hobane moaho o mong le o mong o fana ka maikutlo a litšitiso tse fapaneng tsa tatellano.

  • Tšoara sebaka se nkhang hamonate le marokho a letsoai e le lera la botsitso. Li laola hore na kopano e tšoarella nako e kae ka lera, eseng kamoo e tlamang ka matla kateng.

  • Tšoara ho beoa ha tefiso joalo ka lera la khetho. Moo mesaletsa ea cationic e lutseng e amanang le sefahleho sa hydrophobic e khethollang peptide e khethollang lipakeng tsa eona..

  • Tšoara stereochemistry e le phetoho ea phenotype. Phatlalatso ea D-amino acid ha se mongolo o botlaaseng ba leqephe; e ka tsamaisa peptide lipakeng tsa pore phenotypes.

  • Ikemisetse ho bala mosebetsi pele ho synthesis. Etsa qeto ea tlhahlobo, tsamaiso ea lipid, le likarohano tsa peptide-to-lipid esale pele, kahoo sehlopha sa synthesis se na le seo se lokelang ho lekoa khahlanong le sona.

Ntlha ea bopaki ke hore sena se ka sebetsa ka tekanyo. A 2026 phaephe ea moralo e tlohile ho scan ea 150-peptide in-silico ho 22 li-peptide tse entsoeng, le calcein leakage le computed pore hydration correlating ho pholletsa sete. Peptide ea pele, KDFA2i + 9-NH₂, hlahisoeng ka ho lekana 20% ho lokolloa ha calcein ka tekanyo ea peptide-to-lipid ea 1:2,000, ho phahama ka tekanyo e phahameng (Mokhatlo oa Amerika oa Peptide, 2026). Hlokomela hore na palo eo ke efe: sephetho se sebetsang ka tekanyo e hlalositsoeng tsamaisong e hlalositsoeng, e leng hantle mofuta oa bopaki boo lengolo la tlhahlobo le ke keng la fana ka lona.

Bakeng sa lihlopha tse se nang ka hare ho ntlo synthesis, Liphetoho tsa MOL li tšehetsa moralo oa tatellano ea tloaelo le mosebetsi oa ho fetola, e ka sebelisoang ho fetola moaho o khethiloeng hore e be peptide e hlophisehileng ha tlhahlobo e sebetsang e ntse e le tekong ea hau..

Ha ho le e 'ngoe ea tsena e leng deterministic. Melao ea tatelano-to-pore ke probabilistic, 'me li-peptide tse ling tse entsoeng hantle li ntse li tla hlōleha tlhahlobo ea tsona ea pele. Boleng ba moralo ke hore bo etsa hore ho hloleha ho be le tsebo ho e-na le ho ba le moelelo.

Ho Khetha Litlhahlobo Tse Sebetsang Tse Tlatselletsang Lintlha tsa Bohloeki

phaephe ho tloha ho le letshehadi ho ya ho le letona e bontshang moralo wa tatelano, tloaelo ea synthesis, tlhahlobo ea tlhahiso ea analytical (RP-HPLC, MOF, counterion, nyopa, endotoxin) le ea

Mohato oa pele ke ho khetha tlhahlobo e arabang potso eo tlhahlobo ea bohloeki e ke keng ea khona: eseng “se ka har’a vial ena,” empa “peptide ee e etsa eng ka lera.” Bakeng sa Li-Peptide tsa Synthetic liteko tse sebetsang bakeng sa li-peptide tse sebetsang ka membrane, seo se bolela ho bapisa 'malo le thepa ea pore tlas'a teko ho e-na le ho itloaetsa ho bala hore na ke sefe sa mahala.

Calcein leakage e lekanya ho lokolloa ha dae ho tsoa ho lipid vesicles mme e tlaleha ho kenella ka bongata. DiSC₃-5 depolarization e latela tahlehelo ea bokhoni ba lera ho pholletsa le lera la baktheria, kahoo e tlaleha ho ferekanngoa ha membrane maemong a fisioloji haholoanyane. Planar bilayer single-channel rekota mehato ea hajoale ka pore e le 'ngoe ka nako, e leng yona feela ho tse tharo e rarollang boitshwaro bo le bong.

Ba bararo ba lutse likala tse fapaneng haholo tsa kutlo. Ho lutla ha Calcein hangata ho hloka hore peptide e be teng 1 ho 25 µM e fapana ka sekhahla 20 µM lipid e nang le 75 MM intraliposomal calcein, ha DiSC₃-5 litlamorao tsa depolarization li kopana ho potoloha 19 µM. Mosebetsi oa mocha o le mong o fihla ho sub-micromolar ho ea ho low-micromolar concentrations, ka liphuputso tse hatisitsoeng ho 0.3 µM, 0.8 ho 4.1 µM, le 6.2 µM, ho rarolla litsamaiso ho tloha ka 6 ho 360 pS ho fihlela ho nanosiemens range. Peptide e shebahalang e sa sebetse tekong ea ho lutla e kanna ea ba ka tlase ho mokato oa ho lemoha ha 'malo oo.

Tlhahlobo

E araba potso eo

Taolo e hlokahalang

Sebaka se foufetseng

Calcein leakage

Na peptide e kenya li-bilayers tsa lipid ka bongata?

Li-vesicles tse se nang peptide; detergent bakeng sa 100% lokolla

Karolelano ea li-pores tsa nakoana kapa tse sa tloaelehang

DiSC₃-5 depolarization

E senya bokhoni ba membrane?

Taolo ea protonophore; lera le se nang peptide

Ha e khone ho arola sebopeho sa pore ho tsoa ho membrane solubilization

Planar bilayer single-channel

Mokhoa oa bonngoe le bophelo bohle ba pore e le 'ngoe ke eng?

Bilayer e se nang peptide; li-voltage-reversal runs

Mosebetsi o fokolang; lesoba le le leng le ka 'na la se ke la emela baahi

Sebaka se foufetseng moleng oa pele ha se khopolo-taba. D-peptide e thehiloeng ho Wza, DcWza, a hlahisa unitary conductance ea 0.95 ± 0.1 nS ho +200 mV ka 1 M KCl ka mose 50 diketsahalo, leha ho le joalo vesicle permeabilization ka mor'a hora e le 'ngoe 4.6 ± 2.5% kgahlanong le taolo ya 4.2 ± 2.1% (Fumana et al., Tlhaho Puisano, 2022). Li-pores tsa nakoana tse ntšang ho e-na le hore li tsoele pele li siea mohlala o mong oa ho lutla ka bongata. Ho joalo bakeng sa ho tsamaisa mosebetsi oa mocha o le mong hammoho, eseng sebakeng sa, liteko tsa vesicle.

Phethahatso, ka tatellano:

  1. Hlalosa mohlala oa membrane le sebopeho sa lipid. Bapisa motsoako oa lipid le lera la tlhaho leo u le tsotellang. Ho hlola kapele: letsatsi la ho bala le ho etsa qeto.

  2. Khetha mokhoa oa ho bala. Ho lutla ha bongata bakeng sa pasa ea pele, depolarization bakeng sa boemo ba fisioloji, mocha o le mong bakeng sa mochine. Nako e telele: li-rigs tsa mocha o le mong li nka libeke ho qala.

  3. Lokisa ditaolo. Li-vesicle tse se nang peptide, moferefere o motle, le sekheo sa solvent-feela. Ho hlola kapele, empa ho e tlola ho sitisa ntho e nngwe le e nngwe e tlase.

  4. Beha sebaka sa mahloriso. Arola bonyane liodara tse peli tsa boholo ho potoloha moeli oo u o lebelletseng, 'me u hopole mekato ea ho lemoha ka holimo.

  5. Ngolisa esale pele mokhoa oa ho pasa. Ngola hore na ke lintho life tse sebetsang pele u tsamaisa poleiti. Ona ke mohato oo lihlopha tse ngata li o tlolang le ho ikoahlaela haholo.

Lekanya sekhahla sa ho lutla, boitsoaro bo kopaneng, le karo-karolelano ea khetho. Nako ea nnete ke libeke tse peli ho isa ho tse 'ne bakeng sa tlhahlobo ea vesicle e netefalitsoeng le likhoeli tse peli ho isa ho tse tharo pele data ea mocha o le mong e fihla boemong ba phatlalatso..

Li-Caveats le Moo Pono e Tloaelehileng e sa ntseng e tšoaretsoe teng

Melao ea moralo e ka etsahala, eseng deterministic, 'me li-pores tse ling tse entsoeng li hlōleha. Eo ke moeli oa bohlokoa ka ho fetisisa oa ho bolela ka ho hlaka, hobane hape ke lebaka le tšepahalang la bohloeki-ho nahana pele ho tsoela pele: bohloeki bo ka lekanngoa, e phetoang, le theko e tlase ho netefatsa, while membrane behavior is none of those things. Tlhahiso ea Peptide

Context matters more than the argument does. For non-membrane targets, or for screening libraries where the readout is binding rather than permeabilization, RP-HPLC and MS purity genuinely is the right release criterion, and peptide purity testing limitations only become a problem when that certificate is asked to answer a question it was never designed to answer.

The weakest part of the case is the evidence base itself. Much of the 2026 design guidance derives from a single coarse-grained MD pipeline run in POPC, and the salt-bridge rescue was demonstrated in simulation before anyone synthesized the peptide. Neither result is wrong; both are narrower than a design rule implies.

Treat the framework as a hypothesis generator, not a specification. E u bolella hore na ke lintlafatso life tse lokelang ho etsoa le hore na ke litlhahlobo life tse lokelang ho etsoa, 'me e ntse e lebeletse hore tse ling tsa li-pores tseo li hlōlehe.

Empa ha e fane ka Tiisetso ea Bohloeki bo Phahameng ka ho Fetisisa Ts'ebetso ea Membrane?

Che. Bohloeki bo thibela se ka har'a vial, eseng kamoo boitsebiso boo bo bokanang kateng ka bilayer. Tlhaloso ea ≥98% ha e na moelelo, leha ho le joalo: e tlosa sehlopha se seholo sa dipherekano, ho kenyeletsoa tatellano e khutsufalitsoeng, hlakolwa ditshila, le lihlahisoa tsa scavenger tse ka bakang seretse mosebetsi ofe kapa ofe oa ho bala. Seo e sa khoneng ho se etsa ke ho u joetsa hore na peptide ea kenya, oligomerizes, kapa e theha pore ea pore eo moralo oa hau o e nahanang.

Haeba morero o se o koaletsoe ka har'a ts'ebetso ea tokollo ea bohloeki feela, ha ho hlokahale hore u tsosolose lenaneo. Kenya 'malo o le mong oa orthogonal o sebetsang, joalo ka vesicle leakage assay kapa planar bilayer conductance measurement, le ho e sebelisa ho netefatsa hore lotho e lokollotsoeng e sebetsa joalo ka moralo o reriloeng.

Tšoara tšebetso e tlalehiloeng ho tsoa ho peptide e tšoauoang feela ke HPLC le MS e le ea nakoana. Ntle le maemo a tlhahlobo a bonahalang le taolo, u ke ke ua tseba hore na phello e bonoang e tsoa ho peptide, sekoahelo se setseng, kapa buffer.

Qetello: Ho tloha Setifikeiti sa Bohloeki ho ea ho Bopaki bo sebetsang

Bohloeki boa hlokahala empa ha boa lekana bakeng sa pore-forming peptide design: chromatogram e ka tiisa hore na molek'hule ke eng, ha ho mohla e etsang lera.

Phetoho e sebetsang e maemong a tokollo. Bakeng sa li-peptide tse sebetsang ka membrane, Lintlha tsa tlhahlobo li lokela ho tsamaea bonyane le 'malo o le mong o sebetsang, le linomoro tsa mesebetsi e hatisitsoeng li lokela ho fihla hammoho le maemo a liteko le litsamaiso tse li hlahisitseng. Ho kopanya hoo ke hona ho etsang hore sephetho se ka hlahisoa matsohong a motho e mong eseng feela ka laboratoring e se hlahisitseng..

Ha ho le e 'ngoe ea tsena e u kopang ho tsosolosa lenaneo le seng le ntse le le teng. Qala ka ho etsa 'mapa oa likarolo tsa tatellano eo u seng u ntse u e laola holim'a boitšoaro ba membrane boo u bo hlokang, ebe u khetha tlhahlobo e lemohang boitšoaro boo. Moralo oa tšebetso le lethathamo la libopeho li ka hlakisa 'mapa ona pele lotho e latelang e laeloa.

Tsela ea ho tsamaea e lebisa melaong ea moralo e ka khonehang empa e ka sebelisoa: e lekaneng ho fokotsa sebaka sa tatelano, botshepehi ho lekana ho bolela ha pore e entsoeng e ke ke ea itšoara ka tsela e reriloeng.

Admin Avatar

Jinling Liu

Mokhoa oa R&D le Setsebi sa Tlhahiso Tsebo ea Konokono: Ts'ebetso ea ntlafatso, k'hemistri e tala, ntlafatso ea lihlahisoa, Ho lumellana ha tlhahiso ea GMP.

Profile: Jinling Liu o sebetsa ka thata ho fetolela lithethefatsi tsa peptide ho tsoa sekaleng sa laboratori (boemo ba milligram) ho tlhahiso ea maemo a khoebo (boima ba lik'hilograma). O ikemiselitse ho fokotsa haholo litšenyehelo tsa tlhahiso ea peptide le ho fokotsa tšilafalo ea tikoloho ka ho ntlafatsa maemo a ho qhekella., ho ntlafatsa likarolo tsa li-reagents tsa condensation, le ho hlahisa thekenoloji ea continuous-flow synthesis. O etelletse pele ts'ebetsong ea merero e mengata ea peptide, ho fihlella ka katleho theko e tlase, tlhahiso ea boima bo phahameng ka tekanyo ea lik'hilograma tse 100.

'Nete e hlahlobiloe & Litaelo tsa Bahlophisi
E hlahlojoa ke: Litsebi tsa Litaba
Arolelana sehlooho sena
Lehae Batla Whatsapp Litšebeletso Sehlahisoa